Post Brain Aneurysm Clipping Monitoring Protocol

Immediate Postoperative Phase (0-24 hours)

• Patients who undergo surgical clipping of a ruptured aneurysm require intensive neurological monitoring in a specialized neurocritical care unit with continuous arterial blood pressure monitoring, frequent neurological examinations, and multimodal surveillance for delayed cerebral ischemia during the critical 4-14 day post-hemorrhage period, as recommended by the American Heart Association 1, 2
• Perform hourly neurological examinations focusing on level of consciousness, pupillary response, motor strength, and speech to detect early signs of hematoma, ischemia, or cerebral edema, with high sensitivity and specificity 3, 4
• Monitor for postoperative nausea and vomiting (occurs in 22-70% of craniotomy patients) using multimodal antiemetic regimens targeting different chemoreceptors 4
• Maintain continuous arterial line monitoring for precise blood pressure control, as non-invasive cuff monitoring is inadequate for the rapid titration required 5
• Target systolic blood pressure <160 mmHg if aneurysm obliteration is incomplete or uncertain, using short-acting titratable agents like nicardipine or clevidipine, as recommended by the American College of Cardiology 1, 3, 5
• Maintain mean arterial pressure >90 mmHg once complete aneurysm obliteration is confirmed to prevent delayed cerebral ischemia, with a strength of evidence level of IIa 5
• Avoid blood pressure variability and rapid fluctuations (>70 mmHg drop in 1 hour), which are associated with worse outcomes, with a strength of evidence level of IIb 5
• Maintain strict normoglycemia (glucose 80-180 mg/dL), as perioperative hyperglycemia is associated with poor long-term cognitive and neurological outcomes, with a strength of evidence level of III 4
• Monitor for and aggressively treat fever to normothermia using standard or advanced temperature modulating systems, with a strength of evidence level of III 3

Acute Phase (Days 1-14): Delayed Cerebral Ischemia Surveillance

• Perform neurological examinations every 2-4 hours during the peak DCI period (days 4-12), looking specifically for new focal deficits, decreased level of consciousness, or aphasia, as recommended by the American Heart Association 1, 2
• Maintain euvolemia rather than hypervolemia to prevent symptomatic vasospasm, with a strength of evidence level of IIa 5
• Implement daily transcranial Doppler ultrasound to monitor for development of arterial vasospasm, with particular attention to mean flow velocities >120 cm/sec in the middle cerebral artery, with a strength of evidence level of IIb 3
• Obtain CT or MRI perfusion imaging when clinical examination deteriorates or transcranial Doppler suggests significant vasospasm, to identify regions of potential brain ischemia, with a strength of evidence level of III 3
• Induce hypertension (MAP >90-110 mmHg) as first-line treatment for symptomatic vasospasm in the absence of cardiac contraindications, with continuous arterial monitoring to maintain precise targets, as recommended by the American College of Cardiology 5
• Avoid prophylactic hypervolemia or balloon angioplasty before development of angiographic spasm, with a strength of evidence level of III 3

Subacute Phase (Days 14-30)

• Monitor for signs of hydrocephalus (decreased consciousness, gait disturbance, incontinence), with a strength of evidence level of III 3
• If external ventricular drain is present, wean over >24 hours does not reduce need for permanent shunting, with a strength of evidence level of III 3
• Screen for deep venous thrombosis and heparin-induced thrombocytopenia, as these are relatively frequent complications requiring early identification and targeted treatment, with a strength of evidence level of IIa 3
• Consider packed red blood cell transfusion for patients at risk of cerebral ischemia, though optimal hemoglobin threshold remains undetermined, with a strength of evidence level of IIb 3

Follow-Up Imaging Protocol

• Obtain postoperative catheter angiography (DSA) within 24-72 hours to confirm complete aneurysm obliteration, as this is the gold standard for assessing clip placement, as recommended by the American College of Radiology 1, 6
• Perform delayed follow-up vascular imaging (timing and modality individualized) for all patients, as aneurysm remnants occur in up to 11% of clipped aneurysms, with a strength of evidence level of IIa 1, 2, 6
• Strong consideration should be given to retreatment (repeat clipping or coiling) if there is a clinically significant or growing remnant, with a strength of evidence level of IIb 1, 2
• Catheter angiography (DSA) with 3D rotational angiography remains the reference standard for follow-up of clipped aneurysms, with superior visualization despite metallic artifact, as recommended by the American College of Radiology 6
• CTA head can be used for surveillance but is limited by metallic streak artifacts from clips, with a strength of evidence level of III 6
• MRA head at 3T strength offers non-invasive surveillance with 95% sensitivity, though clip artifacts may limit evaluation, with a strength of evidence level of III 6

Critical Pitfalls to Avoid

• Never delay treatment transfer: Low-volume hospitals (<10 aSAH cases/year) should transfer patients to high-volume centers (>35 cases/year) with multidisciplinary neurocritical care, as recommended by the American Heart Association 1, 2
• Avoid hypotension (MAP <65 mmHg) at all times, as this compromises cerebral perfusion and increases ischemia risk, with a strength of evidence level of IIa 5
• Do not use prophylactic hyperdynamic therapy for vasospasm prevention, as this is not recommended, with a strength of evidence level of III 5
• Never assume complete obliteration without imaging confirmation, as incomplete clipping significantly increases rebleeding and retreatment risk, with a strength of evidence level of IIb 1

Anticoagulation Management

• Discontinue all anticoagulants and antiplatelets during the acute period (at least 1-2 weeks), with a strength of evidence level of IIa 7
• Resume anticoagulation after 3-4 weeks with rigorous monitoring, maintaining INR in lower therapeutic range, only after confirming complete aneurysm obliteration, with a strength of evidence level of IIb 7

Rehabilitation and Discharge Planning

• Refer patients for comprehensive evaluation including cognitive, behavioral, and psychosocial assessments after discharge, with a strength of evidence level of III 3